Impairment of adipsin expression is secondary to the onset of obesity in db/db mice

I Dugail1, A Quignard-Boulangé, X Le Liepvre

  • 1Unité de Recherches sur la Physiopathologie de la Nutrition Inserm U177, Paris, France.

Insights

Adipsin deficiency is not the cause of obesity in db/db mice. Studies show adipsin expression is normal in young obese mice, only becoming deficient later, indicating it

Area of Science:

  • Biochemistry
  • Genetics
  • Obesity Research

Background:

  • Genetically obese mice (db/db and ob/ob) are models for human obesity, but primary biochemical defects are unknown.
  • Suppressed adipsin expression in adult obese mice suggested a role in obesity pathogenesis.
  • For etiological significance, adipsin deficiency must occur early in life during fat accumulation.

Purpose of the Study:

  • To investigate the temporal relationship between adipsin expression and adipose tissue development in early-stage db/db mice.
  • To determine if early adipsin deficiency contributes to the onset of obesity in this genetic model.

Main Methods:

  • Comparison of adipose tissue development in db/db pups and lean (+/db) littermates at 10 days of age.
  • Quantification of adipose tissue adipsin mRNA and serum adipsin levels in db/db mice at 10, 15, and 30 days of age.
  • Assessment of hyperinsulinemia development in db/db mice.

Main Results:

  • At 10 days, db/db pups showed significantly more adipose tissue than lean controls, but with similar adipsin mRNA and serum levels.
  • Adipsin expression remained normal in obese mice at 15 days.
  • Adipsin deficiency was evident at 30 days, coinciding with the development of hyperinsulinemia.

Conclusions:

  • The defect in adipsin expression in db/db mice is a secondary phenomenon.
  • Adipsin deficiency does not play a primary etiological role in the onset of obesity in this model.
  • Early adipose tissue overdevelopment precedes adipsin suppression in db/db mice.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.